Literature DB >> 16520858

Myocardial infarction associated with pseudoephedrine use and acute streptococcal infection in a boy with normal coronary arteries.

Ismail Biyik1, Oktay Ergene.   

Abstract

A 16-year-old boy presented to the emergency department with chest pain. He had no history of other health problems and did not smoke. Acute myocardial infarction (AMI) in an adolescent boy with normal coronary arteries, associated with pseudoephedrine use and acute streptococcal infection, is reported. The diagnosis of AMI was based on typical electrocardiographic signs, enzyme changes and echocardiographic evaluation. Coronary vasospasm associated with pseudoephedrine use, endothelial dysfunction and prothrombotic state caused by acute streptococcal infection may be the mechanisms responsible for AMI in this case. The possibility of AMI should be considered even in very young adolescents that have acute streptococcal pharyngeal infection, and it is important to obtain a complete history of the drugs used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520858      PMCID: PMC2528917          DOI: 10.1016/s0828-282x(06)70906-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  17 in total

1.  Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction?

Authors:  K Bhagat; R Moss; J Collier; P Vallance
Journal:  Cardiovasc Res       Date:  1996-11       Impact factor: 10.787

Review 2.  Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

Authors:  P Vallance; J Collier; K Bhagat
Journal:  Lancet       Date:  1997-05-10       Impact factor: 79.321

Review 3.  The possible role of infections in acute myocardial infarction.

Authors:  C R Meier
Journal:  Biomed Pharmacother       Date:  1999-10       Impact factor: 6.529

4.  Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries.

Authors:  P Ammann; S Marschall; M Kraus; L Schmid; W Angehrn; R Krapf; H Rickli
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

5.  Acute myocardial infarction after over-the-counter use of pseudoephedrine.

Authors:  Alex F Manini; Christopher Kabrhel; Todd W Thomsen
Journal:  Ann Emerg Med       Date:  2005-02       Impact factor: 5.721

6.  Acute myocardial ischemia associated with ingestion of bupropion and pseudoephedrine in a 21-year-old man.

Authors:  K J Pederson; D H Kuntz; G J Garbe
Journal:  Can J Cardiol       Date:  2001-05       Impact factor: 5.223

Review 7.  Myocardial infarction with angiographically normal coronary arteries.

Authors:  J S Alpert
Journal:  Arch Intern Med       Date:  1994-02-14

8.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).

Authors:  F H Zimmerman; A Cameron; L D Fisher; G Ng
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

9.  TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit.

Authors:  V Evangelista; G Dell'Elba; A Celardo; S Manarini; C Cerletti
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

10.  Myocardial infarction with normal coronary arteriogram: the role of ephedrine-like alkaloids.

Authors:  Grzegorz Grześk; Gwidon Polak; Zofia Grabczewska; Jacek Kubica
Journal:  Med Sci Monit       Date:  2004-04
View more
  4 in total

1.  Effect of pseudoephedrine on cardiac rhythm of children with rhinitis.

Authors:  Meki Bilici; Sadi Turkay; Ayse Esra Yılmaz; Hanifi Kurtaran; Ferhat Catal; Alparslan Tonbul; Yusuf Selcoki; Utku Arman Orun
Journal:  Indian J Pediatr       Date:  2011-06-03       Impact factor: 1.967

2.  ST elevation myocardial infarction after use of pseudoephedrine : which is more dangerous, the common cold itself or the medication used for it?

Authors:  S Fidan; S Izci; M Tellice; E Alizade; G Açar
Journal:  Herz       Date:  2013-09-04       Impact factor: 1.443

3.  Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy.

Authors:  Serhat Akay; Metehan Ozdemir
Journal:  Can J Cardiol       Date:  2008-11       Impact factor: 5.223

Review 4.  In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine.

Authors:  Antonio Munafò; Stefano Frara; Andrea Giustina; Renato Bernardini; Norberto Perico; Rosaria Di Mauro; Monica Cortinovis; Chiara Burgaletto; Giuseppina Cantarella; Giuseppe Remuzzi
Journal:  Rev Endocr Metab Disord       Date:  2021-05-04       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.